Jun 2026 (Q1 FY27) — Aug 6, 2026
Lionsgate Q1 FY27 — Strong Film Performance and Accelerated Deleveraging
Read the full callLionsgate (LION) earnings
- Jun 2026
- Jun 2026 (Q1 FY27)
- Mar 2026
Lionsgate earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 777 | +47.7% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 3.3 | +5.3 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -28.8 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$10.62 −0.75% · −$0.08
Performance +79.7% 1Y
1Y: $5.91 on 17 Oct 2025 → $10.62. High $16.4 (26 Jun 2026), low $5.91 (17 Oct 2025).
- Previous close
- $10.7
- 52-week range
- $6 – $16.4
- One year
- +77.00%
Overview
- Symbol
- LION
- Sector
- Information Technology
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q4 FY26) — May 21, 2026
Lionsgate Studios Q4 FY26 — Strong Film Performance Drives Growth and Deleveraging
Read the full callEvery analysed call
Lionsgate earnings calls (LION)
Financials
What the filings say
Net profit, year on year: +74% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 604 | 628 | 1,476 | 526 | 475 | 724 | 907 | 777 |
| Expenses | 705 | 601 | 1,256 | 537 | 521 | 688 | 789 | 751 |
| Operating profit | -101 | 28 | 220 | -11 | -46 | 36 | 118 | 26 |
| Operating margin | −16.7% | 4.4% | 14.9% | −2.0% | −9.7% | 5.0% | 13.0% | 3.3% |
| Interest | 68 | 64 | 47 | 69 | 67 | 65 | 59 | 57 |
| Profit before tax | -180 | -15 | 168 | -85 | -110 | -38 | 74 | -21 |
| Tax rate | −2.2% | −27.9% | 0.4% | −7.5% | −1.6% | −17.8% | 1.8% | −36.3% |
| Net profit | -163 | -22 | 116 | -109 | -113 | -46 | 70 | -29 |
| EPS ($ per share) | -0.66 | -0.09 | — | -0.40 | -0.39 | -0.16 | — | -0.10 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity capital | — | — | 0 | 0 | 2,497 |
| Reserves | — | — | -1,249 | -3,534 | -3,733 |
| Total liabilities | — | — | 6,130 | 7,081 | 6,377 |
| Fixed assets | — | — | 37 | 34 | 35 |
| Total assets | — | — | 5,103 | 6,822 | 5,327 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Cash from operations | 346 | 397 | -166 | 25 |
| Cash from investing | 31 | -377 | -53 | -9 |
| Cash from financing | -394 | 40 | 144 | 111 |
| Capital expenditure | -6 | -10 | -13 | -13 |
| Free cash flow | 340 | 387 | -179 | 11 |
Insider filings
117 filings between Nov 28, 2025 and Sep 15, 2026.
Open market
decisions to buy or sellPurchases
$0
7 purchases by 1 insider
Sales
$2.02M
8 sales by 4 insiders
Some filings report no price, so the dollar figures above are a floor, not a total.
Compensation
not trading decisions- 61
- Award — granted as compensation
- 41
- Tax withheld — shares kept back by the company to cover tax
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| FELTHEIMER JON | — | $1.61M | Dec 22, 2025 |
| Goldsmith Brian | — | $213.5K | Dec 18, 2025 |
| BURNS MICHAEL RAYMOND | — | $195.9K | Dec 23, 2025 |
| RACHESKY MARK H MD | $0 | $0 | Jul 8, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | FINE EMILY Director | Award | 4,468 | $50.0K |
| Sep 15, 2026 | SLOAN HARRY Director | Award | 5,362 | $60.0K |
| Sep 15, 2026 | HARKEY JOHN D JR Director | Award | 13,405 | $0 |
| Sep 15, 2026 | Crawford Gordon Director | Award | 4,468 | $50.0K |
| Sep 15, 2026 | RACHESKY MARK H MD Director | Award | 6,792 | $76.0K |
| Sep 15, 2026 | McCaw Susan Director | Award | 13,405 | $0 |
| Sep 15, 2026 | Rosenblatt M Richard Director | Award | 13,405 | $0 |
| Sep 15, 2026 | HARKEY JOHN D JR Director | Award | 5,809 | $65.0K |
| Sep 15, 2026 | RACHESKY MARK H MD Director | Award | 13,405 | $150.0K |
| Sep 15, 2026 | Ostolaza Yvette Director | Award | 13,405 | $0 |
| Sep 15, 2026 | Ostolaza Yvette Director | Award | 5,362 | $60.0K |
| Sep 15, 2026 | FINE EMILY Director | Award | 13,405 | $150.0K |
| Sep 15, 2026 | Crawford Gordon Director | Award | 13,405 | $0 |
| Sep 15, 2026 | SLOAN HARRY Director | Award | 13,405 | $0 |
| Sep 15, 2026 | Rosenblatt M Richard Director | Award | 4,468 | $50.0K |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Sale | 1,469,450 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 671,924 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 11,154,680 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Sale | 25,173,882 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 11,755,412 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Sale | 11,755,412 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 15,804,919 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 499,765 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 797,526 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Sale | 3,701,988 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Sale | 499,765 | — |
| Jul 8, 2026 | RACHESKY MARK H MD Director | Purchase | 1,916,271 | — |
| Jul 3, 2026 | FELTHEIMER JON Chief Executive Officer | Tax withheld | 103,669 | $1.52M |
| Jul 3, 2026 | FELTHEIMER JON Chief Executive Officer | Award | 196,902 | $0 |
| Jul 3, 2026 | FELTHEIMER JON Chief Executive Officer | Tax withheld | 103,669 | $1.52M |
| Jul 3, 2026 | BARGE JAMES W Chief Financial Officer | Tax withheld | 32,560 | $477.3K |
| Jul 3, 2026 | BARGE JAMES W Chief Financial Officer | Award | 63,993 | $0 |
| Jul 3, 2026 | Goldsmith Brian Chief Operating Officer | Tax withheld | 35,064 | $514.0K |
| Jul 3, 2026 | BARGE JAMES W Chief Financial Officer | Tax withheld | 32,560 | $477.3K |
| Jul 3, 2026 | BURNS MICHAEL RAYMOND Vice Chair | Tax withheld | 35,064 | $514.0K |
| Jul 3, 2026 | BURNS MICHAEL RAYMOND Vice Chair | Award | 68,926 | $0 |
| Jul 3, 2026 | BURNS MICHAEL RAYMOND Vice Chair | Tax withheld | 35,064 | $514.0K |
| Jul 3, 2026 | Tobey Bruce General Counsel | Tax withheld | 10,018 | $146.9K |
| Jul 3, 2026 | Goldsmith Brian Chief Operating Officer | Tax withheld | 35,064 | $514.0K |
| Jul 3, 2026 | Tobey Bruce General Counsel | Tax withheld | 10,018 | $146.9K |
| Jul 3, 2026 | Goldsmith Brian Chief Operating Officer | Award | 68,916 | $0 |
| Jul 3, 2026 | Tobey Bruce General Counsel | Award | 19,690 | $0 |
| Jul 1, 2026 | FELTHEIMER JON Chief Executive Officer | Tax withheld | 128,378 | $1.97M |
| Jul 1, 2026 | FELTHEIMER JON Chief Executive Officer | Tax withheld | 92,558 | $1.39M |
| Jul 1, 2026 | FELTHEIMER JON Chief Executive Officer | Award | 175,799 | $0 |
| Jul 1, 2026 | FELTHEIMER JON Chief Executive Officer | Tax withheld | 92,558 | $1.42M |
| Jul 1, 2026 | Goldsmith Brian Chief Operating Officer | Tax withheld | 43,422 | $652.6K |
| Jul 1, 2026 | Goldsmith Brian Chief Operating Officer | Award | 85,342 | $0 |
| Jul 1, 2026 | BURNS MICHAEL RAYMOND Vice Chair | Award | 105,479 | $0 |
| Jul 1, 2026 | FELTHEIMER JON Chief Executive Officer | Award | 632,069 | $0 |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Lionsgate Studios Corp.
Free account. Everything above stays public.
Write why you follow Lionsgate Studios Corp. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading